FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3097971076> ?p ?o ?g. }

• W3097971076 endingPage "42" @default.
• W3097971076 startingPage "33" @default.
• W3097971076 abstract "Abstract Background Little is known about the effect of renin angiotensin aldosterone system‐inhibiting (RAASi) drugs on alternative angiotensin peptides (APs) such as angiotensin 1‐7 (Ang1‐7), which are mediated by angiotensin‐converting enzyme 2 (ACE2). Hypothesis/Objectives Angiotensin receptor blockers (ARBs) would alter balance of APs and differences would be magnified in vitro by incubation of plasma samples with recombinant human ACE2 (rhACE2). Animals Six cats with cardiomyopathy (CM), 8 healthy cats. Methods Prospective open label trial. Plasma equilibrium concentrations of APs were measured in healthy cats as well as in CM cats that first received no RAASi drugs (CM noRAASi ) and then after 14 days of PO telmisartan (CM ARB ). Plasma APs also were measured after in vitro incubation with rhACE2. Results No significant differences were found between healthy and CM noRAASi groups. Concentrations of several APs, including angiotensin I (AT1) and angiotensin II (AT2) were significantly different between CM noRAASi and CM ARB groups. Incubation with rhACE2 decreased AT1 and AT2 in both groups. The geometric mean concentration of Ang1‐7 was significantly higher in CM ARB (4.9 pg/mL; 95% confidence interval [CI], 3.7‐6.4 pg/mL) vs CM noRAASi (3.2 pg/mL; 95% CI, 2.2‐4.7 pg/mL; P = .01) and in CM ARB + ACE2 (5.0 pg/mL; 95% CI, 3.9‐6.4 pg/mL) vs CM noRAASi + ACE2 (3.0 pg/mL; 95% CI, 1.7‐5.5 pg/mL; P = .01). The most favorable theoretical AP profile that maximized Ang1‐7 and other alternative APs was CM ARB + ACE2. Conclusions and Clinical Importance Balance between traditional and alternative APs can be favorably shifted using ARBs and in vitro incubation with rhACE2. These data shed light on new AP‐targeting strategies in cats with CM." @default.
• W3097971076 created "2020-11-09" @default.
• W3097971076 creator A5033677774 @default.
• W3097971076 creator A5043180609 @default.
• W3097971076 creator A5073582935 @default.
• W3097971076 creator A5091393051 @default.
• W3097971076 date "2020-11-02" @default.
• W3097971076 modified "2023-09-26" @default.
• W3097971076 title "Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease" @default.
• W3097971076 cites W1870422863 @default.
• W3097971076 cites W1984026103 @default.
• W3097971076 cites W1991389439 @default.
• W3097971076 cites W1998091339 @default.
• W3097971076 cites W2000040025 @default.
• W3097971076 cites W2005812163 @default.
• W3097971076 cites W2006584351 @default.
• W3097971076 cites W2006825109 @default.
• W3097971076 cites W2010500162 @default.
• W3097971076 cites W2025825600 @default.
• W3097971076 cites W2026964201 @default.
• W3097971076 cites W2033202346 @default.
• W3097971076 cites W2040418189 @default.
• W3097971076 cites W2053533323 @default.
• W3097971076 cites W2055674583 @default.
• W3097971076 cites W2065165773 @default.
• W3097971076 cites W2066534725 @default.
• W3097971076 cites W2086052108 @default.
• W3097971076 cites W2090662855 @default.
• W3097971076 cites W2128383622 @default.
• W3097971076 cites W2157114317 @default.
• W3097971076 cites W2161399617 @default.
• W3097971076 cites W2162010380 @default.
• W3097971076 cites W2168800815 @default.
• W3097971076 cites W2178738676 @default.
• W3097971076 cites W2337855427 @default.
• W3097971076 cites W2522381157 @default.
• W3097971076 cites W2588199171 @default.
• W3097971076 cites W2609605008 @default.
• W3097971076 cites W2776881526 @default.
• W3097971076 cites W2792536986 @default.
• W3097971076 cites W2799694745 @default.
• W3097971076 cites W2905328403 @default.
• W3097971076 cites W2915506231 @default.
• W3097971076 cites W2953604264 @default.
• W3097971076 cites W2955752241 @default.
• W3097971076 cites W2975989653 @default.
• W3097971076 cites W2991478647 @default.
• W3097971076 cites W3007803872 @default.
• W3097971076 cites W3097971076 @default.
• W3097971076 cites W4229773909 @default.
• W3097971076 cites W4243522644 @default.
• W3097971076 doi "https://doi.org/10.1111/jvim.15948" @default.
• W3097971076 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7848384" @default.
• W3097971076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33368659" @default.
• W3097971076 hasPublicationYear "2020" @default.
• W3097971076 type Work @default.
• W3097971076 sameAs 3097971076 @default.
• W3097971076 citedByCount "15" @default.
• W3097971076 countsByYear W30979710762020 @default.
• W3097971076 countsByYear W30979710762021 @default.
• W3097971076 countsByYear W30979710762022 @default.
• W3097971076 countsByYear W30979710762023 @default.
• W3097971076 crossrefType "journal-article" @default.
• W3097971076 hasAuthorship W3097971076A5033677774 @default.
• W3097971076 hasAuthorship W3097971076A5043180609 @default.
• W3097971076 hasAuthorship W3097971076A5073582935 @default.
• W3097971076 hasAuthorship W3097971076A5091393051 @default.
• W3097971076 hasBestOaLocation W30979710761 @default.
• W3097971076 hasConcept C104849204 @default.
• W3097971076 hasConcept C123915805 @default.
• W3097971076 hasConcept C126322002 @default.
• W3097971076 hasConcept C134018914 @default.
• W3097971076 hasConcept C138976137 @default.
• W3097971076 hasConcept C170493617 @default.
• W3097971076 hasConcept C185592680 @default.
• W3097971076 hasConcept C198710026 @default.
• W3097971076 hasConcept C25642318 @default.
• W3097971076 hasConcept C27016395 @default.
• W3097971076 hasConcept C2778525890 @default.
• W3097971076 hasConcept C2779716603 @default.
• W3097971076 hasConcept C2779904517 @default.
• W3097971076 hasConcept C2908929049 @default.
• W3097971076 hasConcept C55493867 @default.
• W3097971076 hasConcept C71924100 @default.
• W3097971076 hasConcept C84393581 @default.
• W3097971076 hasConceptScore W3097971076C104849204 @default.
• W3097971076 hasConceptScore W3097971076C123915805 @default.
• W3097971076 hasConceptScore W3097971076C126322002 @default.
• W3097971076 hasConceptScore W3097971076C134018914 @default.
• W3097971076 hasConceptScore W3097971076C138976137 @default.
• W3097971076 hasConceptScore W3097971076C170493617 @default.
• W3097971076 hasConceptScore W3097971076C185592680 @default.
• W3097971076 hasConceptScore W3097971076C198710026 @default.
• W3097971076 hasConceptScore W3097971076C25642318 @default.
• W3097971076 hasConceptScore W3097971076C27016395 @default.
• W3097971076 hasConceptScore W3097971076C2778525890 @default.
• W3097971076 hasConceptScore W3097971076C2779716603 @default.
• W3097971076 hasConceptScore W3097971076C2779904517 @default.

• next